222 related articles for article (PubMed ID: 34019560)
1. Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
Congly SE; Shaheen AA; Swain MG
PLoS One; 2021; 16(5):e0251741. PubMed ID: 34019560
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.
Tapper EB; Sengupta N; Hunink MG; Afdhal NH; Lai M
Am J Gastroenterol; 2015 Sep; 110(9):1298-304. PubMed ID: 26303130
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
Tapper EB; Hunink MG; Afdhal NH; Lai M; Sengupta N
PLoS One; 2016; 11(2):e0147237. PubMed ID: 26905872
[TBL] [Abstract][Full Text] [Related]
4. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
Serra-Burriel M; Graupera I; Torán P; Thiele M; Roulot D; Wai-Sun Wong V; Neil Guha I; Fabrellas N; Arslanow A; Expósito C; Hernández R; Lai-Hung Wong G; Harman D; Darwish Murad S; Krag A; Pera G; Angeli P; Galle P; Aithal GP; Caballeria L; Castera L; Ginès P; Lammert F;
J Hepatol; 2019 Dec; 71(6):1141-1151. PubMed ID: 31470067
[TBL] [Abstract][Full Text] [Related]
5. Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD.
Cassinotto C; Boursier J; Paisant A; Guiu B; Irles-Depe M; Canivet C; Aube C; de Ledinghen V
Hepatology; 2021 Jun; 73(6):2196-2205. PubMed ID: 33236409
[TBL] [Abstract][Full Text] [Related]
6. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
Srivastava A; Jong S; Gola A; Gailer R; Morgan S; Sennett K; Tanwar S; Pizzo E; O'Beirne J; Tsochatzis E; Parkes J; Rosenberg W
BMC Gastroenterol; 2019 Jul; 19(1):122. PubMed ID: 31296161
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis.
Ayonrinde OT; Zelesco M; Welman CJ; Abbott S; Adris N
Intern Med J; 2022 Apr; 52(4):640-650. PubMed ID: 34726820
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
[No Abstract] [Full Text] [Related]
10. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease.
Karagiannakis DS; Markakis G; Lakiotaki D; Cholongitas E; Vlachogiannakos J; Papatheodoridis G
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):961-966. PubMed ID: 35913779
[TBL] [Abstract][Full Text] [Related]
11. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
12. Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis.
Crossan C; Majumdar A; Srivastava A; Thorburn D; Rosenberg W; Pinzani M; Longworth L; Tsochatzis EA
Liver Int; 2019 Nov; 39(11):2052-2060. PubMed ID: 31332938
[TBL] [Abstract][Full Text] [Related]
13. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
14. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.
Kjaergaard M; Lindvig KP; Thorhauge KH; Andersen P; Hansen JK; Kastrup N; Jensen JM; Hansen CD; Johansen S; Israelsen M; Torp N; Trelle MB; Shan S; Detlefsen S; Antonsen S; Andersen JE; Graupera I; Ginés P; Thiele M; Krag A
J Hepatol; 2023 Aug; 79(2):277-286. PubMed ID: 37088311
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
[TBL] [Abstract][Full Text] [Related]
16. Cost Effectiveness of Different Strategies for Detecting Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Based on United States Health Care System.
Vilar-Gomez E; Lou Z; Kong N; Vuppalanchi R; Imperiale TF; Chalasani N
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2305-2314.e12. PubMed ID: 32289535
[TBL] [Abstract][Full Text] [Related]
17. Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.
Tomeno W; Imajo K; Kuwada Y; Ogawa Y; Kikuchi M; Honda Y; Kato T; Kessoku T; Kirikoshi H; Yoneda M; Kitahora T; Saito S; Ozawa Y; Nakajima A
J Gastroenterol Hepatol; 2019 Aug; 34(8):1411-1416. PubMed ID: 30506860
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease.
Takeuchi H; Sugimoto K; Oshiro H; Iwatsuka K; Kono S; Yoshimasu Y; Kasai Y; Furuichi Y; Sakamaki K; Itoi T
J Med Ultrason (2001); 2018 Apr; 45(2):243-249. PubMed ID: 29128938
[TBL] [Abstract][Full Text] [Related]
19. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
[TBL] [Abstract][Full Text] [Related]
20. Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease.
Moini M; Onofrio F; Hansen BE; Adeyi O; Khalili K; Patel K
Sci Rep; 2021 Sep; 11(1):19275. PubMed ID: 34588540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
